Section Arrow
Quote
BSGM.NASDAQ
- BioSig Technologies, Inc.
(Financial Status)
Quotes are at least 15-min delayed:2025/04/29 14:19 EDT
Last
 1.015
-0.025 (-2.40%)
Day High 
1.05 
Prev. Close
1.04 
1-M High
1.14 
Volume 
110.67K 
Bid
1.01
Ask
1.02
Day Low
0.9515 
Open
1 
1-M Low
0.4 
Market Cap 
25.22M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.69 
20-SMA 0.62 
50-SMA 0.72 
52-W High 2.57 
52-W Low 0.201 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.75/-0.20
Enterprise Value
25.22M
Balance Sheet
Book Value Per Share
-0.06
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
40.00K
Operating Revenue Per Share
0.02
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
PACBPacific Biosciences of California1.115-0.015-1.33%-- 
BSXBoston Scientific Corp103.03+0.85+0.83%82.3PE
EWEdwards Lifesciences Corp76.4+0.86+1.14%32.28PE
MDTMedtronic plc84.95+0.91+1.08%25.62PE
SENSSenseonics Holdings0.7542+0.0326+4.52%-- 
Quotes are at least 15-min delayed：2025/04/29 14:19 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
BioSig Technologies Inc is a medical device technology company with an advanced digital signal processing technology platform, the PURE EP Platform (PURE EP), that delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias. The PURE EP Platform enables electrophysiologists to acquire raw signal data in real-time, absent unnecessary noise or interference, to maximize procedural success and minimize unnecessary inefficiencies.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.